dasatinib
Ligand Summary
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
UNII: X78UG0A0RN
PubChem: 3062316
Guide to Pharmacology: 5678
ChEMBL: CHEMBL1421
DrugCentral: 785
LyCHI: WHNTF247H22K
Target Activities
278 Activities
Items per page:
10
1 – 10 of 278
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
Kd | ||||||
IC50 | ||||||
Kd | ||||||
Kd | ||||||